{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "REGULAR", "exchange": "PNK", "shortName": "BIONXT SOLUTIONS INC", "longName": "BioNxt Solutions Inc.", "messageBoardId": "finmb_552612397", "exchangeTimezoneName": "America/New_York", "market": "us_market", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.4479, "firstTradeDateMilliseconds": 1574778600000, "regularMarketChange": 0.0, "regularMarketTime": 1684161259, "regularMarketDayHigh": 0.4479, "regularMarketDayRange": "0.4479 - 0.4479", "regularMarketDayLow": 0.4479, "regularMarketVolume": 431, "regularMarketPreviousClose": 0.4479, "fullExchangeName": "Other OTC", "financialCurrency": "CAD", "regularMarketOpen": 0.4479, "averageDailyVolume3Month": 1124, "averageDailyVolume10Day": 340, "fiftyTwoWeekLowChange": 0.4465, "fiftyTwoWeekLowChangePercent": 318.9286, "fiftyTwoWeekRange": "0.0014 - 0.6861", "fiftyTwoWeekHighChange": -0.23820001, "fiftyTwoWeekHighChangePercent": -0.3471797, "fiftyTwoWeekLow": 0.0014, "fiftyTwoWeekHigh": 0.6861, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.11, "sharesOutstanding": 98386896, "bookValue": -0.045, "fiftyDayAverage": 0.4967904, "fiftyDayAverageChange": -0.04889041, "fiftyDayAverageChangePercent": -0.09841255, "twoHundredDayAverage": 0.38082996, "twoHundredDayAverageChange": 0.06707004, "twoHundredDayAverageChangePercent": 0.17611544, "marketCap": 45108008, "priceHint": 4, "priceToBook": -9.953333, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "displayName": "BioNxt", "symbol": "BNXTF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1820 Fir Street", "address2": "Suite 270", "city": "Vancouver", "state": "BC", "zip": "V6J 3B1", "country": "Canada", "phone": "780 818 6422", "website": "https://www.bionxt.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, the United States, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Hugh A. D. Rogers B.Sc., LL.B", "age": 42, "title": "Pres, CEO & Director", "yearBorn": 1980, "fiscalYear": 2021, "totalPay": {"raw": 164489, "fmt": "164.49k", "longFmt": "164,489"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrick Joseph Meagher C.A., CPA", "title": "Chief Financial Officer", "fiscalYear": 2021, "totalPay": {"raw": 6148, "fmt": "6.15k", "longFmt": "6,148"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Thomas  Beckert", "title": "Managing Director of XP Diagnostics GmbH & Vektor Pharma TF GmbH", "fiscalYear": 2021, "totalPay": {"raw": 177471, "fmt": "177.47k", "longFmt": "177,471"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Heinrich  Jehle", "title": "Head of Diagnostic Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Florian A. Sahr", "title": "Head of Project Management", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}